Proteogenomic Analysis of Surgically Resected Lung Adenocarcinoma

INTRODUCTION: Despite apparently complete surgical resection, approximately half of resected early-stage lung cancer patients relapse and die of their disease. Adjuvant chemotherapy reduces this risk by only 5% to 8%. Thus, there is a need for better identifying who benefits from adjuvant therapy, t...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:J Thorac Oncol
Egile Nagusiak: Sharpnack, Michael F., Ranbaduge, Nilini, Srivastava, Arunima, Cerciello, Ferdinando, Codreanu, Simona G., Liebler, Daniel C., Mascaux, Celine, Miles, Wayne O., Morris, Robert, McDermott, Jason E., Sharpnack, James L., Amann, Joseph, Maher, Christopher A., Machiraju, Raghu, Wysocki, Vicki H., Govindan, Ramaswami, Mallick, Parag, Coombes, Kevin R., Huang, Kun, Carbone, David P.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2018
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7135954/
https://ncbi.nlm.nih.gov/pubmed/30017829
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jtho.2018.06.025
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak